CN101461772A - Method for preparing stem cell secretion factor for beauty treatment and skin-protection - Google Patents
Method for preparing stem cell secretion factor for beauty treatment and skin-protection Download PDFInfo
- Publication number
- CN101461772A CN101461772A CNA2009100676348A CN200910067634A CN101461772A CN 101461772 A CN101461772 A CN 101461772A CN A2009100676348 A CNA2009100676348 A CN A2009100676348A CN 200910067634 A CN200910067634 A CN 200910067634A CN 101461772 A CN101461772 A CN 101461772A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- cell
- factor
- stem
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 101
- 230000003796 beauty Effects 0.000 title claims abstract description 26
- 230000028327 secretion Effects 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims description 11
- 210000004027 cell Anatomy 0.000 claims abstract description 48
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- 230000003321 amplification Effects 0.000 claims abstract description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 5
- 239000000047 product Substances 0.000 claims description 22
- 239000006228 supernatant Substances 0.000 claims description 17
- 239000001963 growth medium Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 10
- 238000004321 preservation Methods 0.000 claims description 9
- 210000002514 epidermal stem cell Anatomy 0.000 claims description 8
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 7
- 102000013275 Somatomedins Human genes 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims description 6
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 claims description 6
- 210000001185 bone marrow Anatomy 0.000 claims description 6
- 230000010261 cell growth Effects 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 6
- 239000003102 growth factor Substances 0.000 claims description 6
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 5
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 5
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims description 5
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims description 5
- 102000015696 Interleukins Human genes 0.000 claims description 5
- 108010063738 Interleukins Proteins 0.000 claims description 5
- 108010025020 Nerve Growth Factor Proteins 0.000 claims description 5
- 102000015336 Nerve Growth Factor Human genes 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229940053128 nerve growth factor Drugs 0.000 claims description 5
- 102000003390 tumor necrosis factor Human genes 0.000 claims description 5
- 210000000589 cicatrix Anatomy 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 230000001815 facial effect Effects 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 230000037303 wrinkles Effects 0.000 claims description 4
- 102000016943 Muramidase Human genes 0.000 claims description 3
- 108010014251 Muramidase Proteins 0.000 claims description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 3
- 229960000274 lysozyme Drugs 0.000 claims description 3
- 235000010335 lysozyme Nutrition 0.000 claims description 3
- 239000004325 lysozyme Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000008278 cosmetic cream Substances 0.000 claims description 2
- 230000003511 endothelial effect Effects 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 239000006166 lysate Substances 0.000 claims description 2
- 235000012459 muffins Nutrition 0.000 claims description 2
- 230000008520 organization Effects 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 230000024642 stem cell division Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 238000003860 storage Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 20
- 239000008055 phosphate buffer solution Substances 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 7
- 239000002131 composite material Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000012010 growth Effects 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 210000004504 adult stem cell Anatomy 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 210000004691 chief cell of stomach Anatomy 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000037816 tissue injury Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 238000009168 stem cell therapy Methods 0.000 description 1
- 238000009580 stem-cell therapy Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a preparation method for stem cell secretion factors used for beauty culture and skin protection. The preparation method comprises the following steps: cell separation, stem cell amplification, the acquisition and concentration of a stem cell factor system, and the acquisition of the system containing the stem cell active factors through storage. The system comprises the active factors secreted by various types of currently verified stem cells. The obtained stem cell active factor system neither contains foreign culture solution components nor contains dead cell decomposition components; in addition, the stem cell active factor system can store and maintain the tissue and cell repairing activity for a long period, thereby truly turning the ideal of stem cell beauty culture into a reality, and improving the traditional beauty culture concepts at the biomedical depth. Simultaneously, the preparation method is simple and feasible and is suitable for mass production, thereby providing a shortcut for the stem cells to serve the beauty culture cause.
Description
Technical field
The present invention relates to a kind ofly to can be used for improving looks, the preparation method of the stem cell secretion factor of skin protection.The composite factor of this stem cell secretion can be applied to cosmetics, health product, skin care item.
Background technology
Stem cell is a kind of cell with multidirectional differentiation potential, can be divided into embryonic stem cell and adult stem cell according to the difference of originating.Embryonic stem cell can be divided into any cell of health, so also be myeloid-lymphoid stem cell.Adult stem cell is meant that those have tissue or organ specific stem cell, can be divided into the cell line suitable with its location in adapt circumstance, is called pluripotent stem cell again.Stem cell can directed differentiation in particular environment, thereby reaches the effect of repair tissue and cell injury.The present inventor studies show that (Bc1-2 engineered MSCs inhibited apoptosis andimproved heart function ', Stem Cells, 2007 Aug; 25 (8): 2118-27..) stem cell can come repair tissue by being divided into specific cell, and paracrine action has been brought into play bigger effect in the reparation of tissue.That is to say that in stem-cell therapy tissue injury, the cytokine of stem cell secretion has been brought into play very important effect.This system comprises kind surplus stem cell factor (SCF), endothelial cell growth factor (ECGF) (VEGF), epithelical cell growth factor (EGF), tumor necrosis factor (TNF) hepatocyte growth factor (HGF), nerve growth factor (NGF), fiber mother cell growth factor (FGF), Insulin-Like growth factor (IGF), granulocyte colony-stimulating factor (G-CSF), the interleukin (IL) etc. 20.Wherein (Stem Cell Factor, it is needed SCF) to be not only the activity of earning a bare living, and the work of body is had and repairs in the opposing ionizing radiation and all be absolutely necessary in damaging due to the radiation for stem cell factor.In addition, also contain each collagen type (as I, II, III, IV collagen type) and various lysozyme etc. in the stem cell secretion factor.
Epidermal stem cells is the seed cell of skin renewal.All have every day a large amount of epidermis cell death to come off, the regenerative cell that also has respective numbers is replenished.Along with the increase at people's age, skin spots, wrinkle also increases gradually, epidermis has lost brilliance in the past, everything all comes from going down of epidermal stem cells regeneration capacity, how to make epidermal stem cells keep vigorous metabolism ability, will be the key point that keeps the skin health beauty.
Based on the demand of people to beauty, the exploitation of stem cell beautifying technique and Related product thereof is subjected to the attention of industry day by day.Occur a lot of so-called stem cell products in the market, do not had the feasibility of enforcement from technical standpoint.Chinese patent CN1817339A, N1872025A and CN1817339A patent relate to the content of product and have used active stem cell and Chinese medicinal components, at first how keep the activity of stem cell in the skin protection kind? secondly how to avoid producing the infringement of toxin after the stem cell necrosis to human body? these all are to be worth inquiring into and very insoluble problem.CN1872025A adopts cell breaking technology, and the cell culture technology under the normal condition obtains the stem cell active component.This method of obtaining the stem cell active component lacks foundation.Can't you obtain Fructus Mali pumilae just to cut apple tree broken as you? pulverize cell and just obtained the cell segment.Routine is under the normal growth state, the cell culture supernatant that is obtained, comprising in the supernatant more is metabolic waste, adopts α-MEN (wherein being added with hormone such as dexamethasone) culture medium simultaneously, how effectively removing hormone wherein, all is the problem that it faced.
The somatomedin of interpolation is also arranged in the market as bFGF and EGF in the beauty and skin care product, and the renewal of cell is the process of a system, though single somatomedin be added in a way can irritation cell metabolism, also cause dependency easily.
In summary it can be seen, have broad prospects based on the beauty curing of stem cell, but how science, effectively utilize the special performance of stem cell, develop stem cell beauty and skin care product truly, still allowing is a brand-new problem.
Summary of the invention
The object of the present invention is to provide a kind of preparation method that is used for the stem cell secretion factor of beauty and skin care, stem cell secretion factor can be used for the product of beauty and skin care.
The step that the preparation method that is used for the stem cell secretion factor of beauty and skin care provided by the invention comprises:
1) adopts conventional cell isolation method, from people or mammal respective organization, isolate stem cell.
2) amplification of stem cell, the conventional cultural method with corresponding stem cell comprises the a-MEM culture medium, adds 10% hyclone, 5%CO2 cultivates under 37 ℃ of conditions, regularly changes liquid, goes down to posterity, and then obtains the stem cell of requirement.
3) obtaining of stem cell factor system: in stem cell division the most vigorous period, discard normal culture medium, clean 1-3 time with PBS buffer (phosphate buffer is about pH=7.4), add PBS or normal saline then, cultivation is 4-24 hour in the cell culture incubator.Collect supernatant, can obtain being rich in the solution of stem cell factor system.
4) concentrate, store: the gained centrifugal, remove the cell that is scattered, concentrate, by 1 * 10
6The concentration of individual cell/m1 concentrates, and gets product, in-20 ℃ of long preservation, in order to using.
The secreted stem cell factor system of stem cell that derives from of the present invention, this system comprises stem cell factor (SCF), endothelial cell growth factor (ECGF) (VEGF), epithelical cell growth factor (EGF), tumor necrosis factor (TNF) hepatocyte growth factor (HGF), nerve growth factor (NGF), fiber mother cell growth factor (FGF), Insulin-Like growth factor (IGF), granulocyte colony-stimulating factor (G-CSF), interleukin (IL) etc.In addition, also contain each collagen type (as I, II, III, IV collagen type) and various lysozyme etc. in the stem cell secretion factor.
Stem cell factor system of the present invention is meant: derive from people or mammalian embryonic stem cell, navel blood stem cell, bone marrow stem cell, epidermal stem cells, endothelial stem cell, peripheral hematopoietic stem cells, fat stem cell etc., also can make a general reference all stem cell.
The product of gained of the present invention is equipped with the product that the lysate of medically accepting constitutes compositions as active component, is directly used in the purposes of beauty treatment, skin protection aspect, comprises reduce wrinkle, beauty treatment, speckle dispelling, reparation cicatrix etc.
The product of gained of the present invention can add in the beauty and skin care product of various preparations as active component.Be used to improve looks, the purposes of skin protection aspect, comprise reduce wrinkle, beauty treatment, speckle dispelling, reparation cicatrix etc.
Products obtained therefrom of the present invention can be used for improving looks, the various preparations in injection, facial cream, emulsion, water liquid or the cosmetics commonly used of skin-protection product, and, include but not limited to cleansing cream, cleaning breast, cleansing soap, facial film, astringent, massage cream, emulsion, nourishing cream, cosmetic cream, foundation cream or muffin etc. according to the various product of the skin protection and the beauty treatment of purpose classification.
Do not contain external culture fluid composition in the stem cell active factors system of gained of the present invention, do not contain dead cell cracking composition yet.And can long preservation and keep tissue and cytothesis activity.The present invention utilizes the multidirectional differentiation of stem cell and powerful the of self-replication capacity, external a large amount of expanding stem cells.Have the epidermal stem cells of promotion propagation, promote skin metabolism according to stem cell composite factor system, strengthen the vigor of Skin Cell, promote the effect of cellular material composition exchange, strengthen the absorption of skin other nutrient substance, and the discharging of body intracellular metabolite refuse.Adopt the secretion effect of stem cell under serum-free condition, do not contained the stem cell factor compound system of cell culture medium and cellular component.Because the present invention does not contain external culture medium and cellular component, thereby the injury of having avoided external additive and lysis toxin that skin is caused.Make the stem cell beauty treatment really move towards reality from ideal.In the biomedical degree of depth traditional Aesthetic idea is promoted.It is simple to be somebody's turn to do invention simultaneously, is suitable for large-scale production, serves beautiful cause for the stem cell cell shortcut is provided.
The specific embodiment
Embodiment 1
Mouse embryo stem cell: derive from the biological center of Nankai University
The cultivation of ES cell and amplification: (embryonic stem cell, ES), cell concentration is about 1 * 10 to get the 1ml embryonic stem cell
6Individual cell/ml, syringe or suction pipe piping and druming are for several times, with the assurance is single cell suspension, cell is laid in the culture bottle of former generation mouse embryo fibroblasts (MEF), ES keeps culture medium (Tianjin couple stars Bioisystech Co., Ltd) 10ml and cultivates, and changes culture fluid after the incubated overnight, after 2-3 days, digest, go down to posterity, cultivate again.Above repeatedly operation is to obtain the ES of sufficient amount.
The preparation of stem cell active factors: when the growth of ES cell is the most vigorous (covering with culture bottle 70-80% area approximately), discard culture medium, clean 2-3 time, add 10mlPBS then, continue to cultivate 24 hours with PBS (or normal saline).Get supernatant, centrifugal, must be rich in the stem cell factor system.
Cell dissociation, counting: wash in the culture bottle cell gently 1-2 times with phosphate buffer solution (PBS), add 3ml Digestive system (025% trypsin, 002%RDTA), 37 ℃ are incubated 2-3 minute, and the microscopically observation of cell separates, add and contain serum DMEM culture medium, dispel cell, 1500 rev/mins centrifugal 5 minutes, abandon supernatant, add 5mlPBS, fully dispel cell, carry out cell counting, press 1ml supernatant/1 * 10
6The concentration concentrated supernatant of individual cell.
The preservation of the stem cell composite reactive factor:, put-20 ℃ of refrigerators, but long preservation is standby with the supernatant (one or many merging) after above the concentrating.
Embodiment 2
This embodiment provides the preparation process of the stem cell factor system of derived from bone marrow, and is specific as follows:
1. obtaining of former generation bone marrow stem cell: get healthy people's bone marrow 10ml, PBS is diluted to 20ml, obtain myelomonocyte by Ficoll density gradient centrifugation, have the characteristic of tending to stick on the polystyrene surface, MSCs is separated with hematopoietic cell according to MSCs.Cultivate and began to occur little cell colony in 3 days later on.Cell reaches capacity after about 7-9 days, and go down to posterity this moment.The cell that goes down to posterity behind the 3h is promptly adherent fully, and after 2 days, cell presents typical fibroblast sample form, is evenly distributed in the culture bottle.Cell density promptly reaches 80-90% after 3-4 days.
2. the amplification of cell: when cell density reaches 80-90%, wash in the culture bottle cell gently 1-2 times with phosphate buffer solution (PBS), add 3ml Digestive system (025% trypsin, 002%RDTA), 37 ℃ are incubated 2-3 minute, the microscopically observation of cell separates, add and contain serum α-MEM culture medium, dispel cell, ratio in 3 bottles of 1 bottle of passages goes down to posterity, more joyous culture fluid after 2 days, when cell density reached 80-90% again, above repeatedly operation was to obtain the bone marrow stem cell of sufficient amount.
3. the preparation of stem cell active factors: (cover with culture bottle 70-80% area approximately) when growth of marrow mesenchyme stem cell is the most vigorous, discards culture medium, PBS or normal saline clean 2-3 time, add 10mlPBS then, continue to cultivate 24 hours.Get supernatant, centrifugal, must be rich in the stem cell factor system.Peptic cell carries out cell counting, presses 1ml supernatant/1 * 10
6The concentration concentrated supernatant of individual cell.
4. the preservation of the stem cell composite reactive factor:, put-20 ℃ of refrigerators, but long preservation is standby with the supernatant (one or many merging) after above the concentrating.
Embodiment 3
Present embodiment provides the preparation process of epidermal stem cells active factors system, and is specific as follows:
Cell source: the skin graft (or neonate foreskin) that derives from healthy people.
The isolated culture method of cell: cultivate according to a conventional method, specifically can be with reference to (referring to Zhang Zhuoran chief editor's " cultured cell is learned and cell culture technology ").
The preparation of stem cell active factors: when the epidermal stem cells growth is the most vigorous (covering with culture bottle 70-80% area approximately), discard culture medium, PBS or normal saline clean 2-3 time, add 10mlPBS then, continue to cultivate 24 hours.Get supernatant, centrifugal, must be rich in the supernatant of stem cell factor.Peptic cell carries out cell counting, presses 1ml supernatant/1 * 10
6The concentration concentrated supernatant of individual cell.
The preservation of the stem cell composite reactive factor:, put-20 ℃ of refrigerators, but long preservation is standby with the supernatant (one or many merging) after above the concentrating.
Embodiment 4
The application in cosmetics of embodiment 4, stem cell secretion factor, with stem cell factor system concentrated solution, (the stem cell factor system: ratio cosmetics stock solution) joins in the prescription of cosmetics, and homogenizing is handled, and makes the cosmetics that are rich in the stem cell factor system with 1-10:100.Such cosmetics that contain the stem cell factor system have beauty treatment, defying age, repair cell damage, strengthen the function of skin elasticity, make skin tenderer, beautiful, the more high resilience that becomes.
Claims (6)
1, a kind of preparation method that is used for the stem cell secretion factor of beauty and skin care is characterized in that the step that comprises:
1) separate stem cells: from people or mammal respective organization, isolate stem cell;
2) amplification of stem cell, the conventional cultural method with corresponding stem cell comprises the a-MEM culture medium, adds 10% hyclone, 5%CO2 cultivates under 37 ℃ of conditions, regularly changes liquid, goes down to posterity, and then obtains the stem cell of requirement;
3) obtaining of stem cell factor system: in stem cell division the most vigorous period, discard normal culture medium, with PBS buffer (phosphate buffer, about pH=7.4) clean 1-3 time, add PBS or normal saline then, cultivated 4-24 hour in the cell culture incubator, collect supernatant, can obtain being rich in the solution of stem cell factor system;
4) concentrate, store: the gained centrifugal, remove the cell that is scattered, concentrate, by 1 * 10
6The concentration of individual cells/ml concentrates, and gets product, can be in-20 ℃ of long preservation, in order to using.
2, method according to claim 1, it is characterized in that the described secreted stem cell factor system of stem cell that derives from, this system comprises that this system comprises stem cell factor, endothelial cell growth factor (ECGF), epithelical cell growth factor, tumor necrosis factor hepatocyte growth factor, nerve growth factor, fiber mother cell growth factor, Insulin-Like growth factor, granulocyte colony-stimulating factor, interleukin; In addition, also contain each collagen type in the stem cell secretion factor, comprise I, II, III, IV collagen type, and various lysozyme.
3, method according to claim 1, it is characterized in that described stem cell factor system is meant: derive from people or mammalian embryonic stem cell, navel blood stem cell, bone marrow stem cell, epidermal stem cells, endothelial stem cell, peripheral hematopoietic stem cells, fat stem cell, also can make a general reference all stem cell.
4, method according to claim 1, the product that it is characterized in that gained is equipped with the product that the lysate of medically accepting constitutes compositions as active component, is directly used in beauty treatment, skin protection, comprises, beauty treatment, speckle dispelling, reparation cicatrix.
5, method according to claim 1 is characterized in that the product of gained can add in the beauty and skin care product of various preparations as active component, comprises reduce wrinkle, beauty treatment, speckle dispelling, reparation cicatrix.
6, method according to claim 1, the product that it is characterized in that gained is used for improving looks, the injection of skin-protection product, facial cream, emulsion, liquid preparation, comprises cleansing cream, cleaning breast, cleansing soap, facial film, astringent, massage cream, emulsion, nourishing cream, cosmetic cream, foundation cream or muffin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009100676348A CN101461772A (en) | 2009-01-07 | 2009-01-07 | Method for preparing stem cell secretion factor for beauty treatment and skin-protection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009100676348A CN101461772A (en) | 2009-01-07 | 2009-01-07 | Method for preparing stem cell secretion factor for beauty treatment and skin-protection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101461772A true CN101461772A (en) | 2009-06-24 |
Family
ID=40802709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2009100676348A Pending CN101461772A (en) | 2009-01-07 | 2009-01-07 | Method for preparing stem cell secretion factor for beauty treatment and skin-protection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101461772A (en) |
Cited By (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102068391A (en) * | 2010-12-30 | 2011-05-25 | 广州赛莱拉化妆品科技有限公司 | Application of human steam cell growth factors in cosmetics |
| CN102600057A (en) * | 2012-03-16 | 2012-07-25 | 广州赛莱拉生物科技有限公司 | Human placenta stem cell extractive lyophilized powder as well as preparation method thereof and application thereof |
| CN102895165A (en) * | 2012-10-29 | 2013-01-30 | 重庆市畜牧科学院 | Composite active matters of mask and preparation method of composite active matters |
| CN103110936A (en) * | 2013-03-15 | 2013-05-22 | 余玉宏 | Biological preparation for promoting quick growth and repair of skin tissue |
| CN103784474A (en) * | 2014-01-26 | 2014-05-14 | 广州赛莱拉生物科技有限公司 | Human fat mesenchymal stem cell extract and lyophilized powder and application thereof |
| CN104099294A (en) * | 2013-04-03 | 2014-10-15 | 北京京蒙高科干细胞技术有限公司 | Medium based on stem cell-excreted factor and its preparation method and use method |
| CN104107105A (en) * | 2014-07-22 | 2014-10-22 | 徐妍 | Cell factor cold application system for repairing skin injury and caring skin |
| CN104203211A (en) * | 2012-02-10 | 2014-12-10 | 株式会社加帕尼克 | Iontophoresis method for cosmetics or skin regeneration promoters and proteins using culture supernatant of non-human stem cells as raw materials |
| CN104622777A (en) * | 2015-02-15 | 2015-05-20 | 广州赛莱拉干细胞科技股份有限公司 | Leukocyte extract and preparation method and application thereof |
| CN104662532A (en) * | 2011-03-28 | 2015-05-27 | 约翰·S·阿诺尼 | Commercial methods, processes and systems for collection, cryogenic storage and distribution of cosmetic formulations from obtained stem cell-based biomaterials |
| CN104997708A (en) * | 2015-07-07 | 2015-10-28 | 河南中科干细胞基因工程有限公司 | Obtaining method of stem cell conditioned medium, and application of stem cell conditioned medium in skin ageing resistance |
| CN105030631A (en) * | 2014-12-12 | 2015-11-11 | 黄宗堂 | Stem cell face cream and preparation method thereof |
| CN105078777A (en) * | 2014-05-15 | 2015-11-25 | 金凤华 | Mesenchymal stem cell excreted factor essence, and preparation method and application thereof |
| CN105505851A (en) * | 2014-10-14 | 2016-04-20 | 讯联生物科技股份有限公司 | Composition for promoting growth of dermal papilla cells, pharmaceutical composition and preparation method thereof |
| CN105749347A (en) * | 2016-02-24 | 2016-07-13 | 广州赛莱拉干细胞科技股份有限公司 | Cosmetic filler and preparation method thereof |
| CN106282099A (en) * | 2015-05-29 | 2017-01-04 | 北京汉氏联合生物技术有限公司 | Preparation for the Placenta Hominis Subaerial blue green algae culture fluid of skin nursing and maintenance |
| CN106906268A (en) * | 2017-04-21 | 2017-06-30 | 优立赛尔（嘉兴）生物技术有限公司 | Cosmetically epidermal stem cells growth factor preparation method |
| CN107385007A (en) * | 2017-07-06 | 2017-11-24 | 杭州观梓健康科技有限公司 | A kind of method and its application for screening and contrasting a variety of stem cell secretion factor bioequivalences in people source |
| CN108210441A (en) * | 2016-12-15 | 2018-06-29 | 烟台赛泽生物技术有限公司 | A kind of stem cell deep layer for cosmetology repairs Essence |
| CN109097391A (en) * | 2018-07-11 | 2018-12-28 | 个体化细胞治疗技术国家地方联合工程实验室（深圳） | A kind of method and its application that decidua mescenchymal stem cell active factors are mass produced |
| CN109260139A (en) * | 2018-11-08 | 2019-01-25 | 深圳市茵冠生物科技有限公司 | A kind of stem cell skin care item and preparation method thereof |
| CN109536441A (en) * | 2018-11-30 | 2019-03-29 | 佛山科学技术学院 | A kind of culture medium and preparation method thereof of fatty stem cell secretion object |
| CN110339147A (en) * | 2018-11-27 | 2019-10-18 | 浙江梵泊细胞工程有限公司 | A kind of composition for external application and application thereof |
| CN110812309A (en) * | 2019-11-08 | 2020-02-21 | 曹文雁 | Formula for improving skin |
| CN111643390A (en) * | 2020-07-16 | 2020-09-11 | 卡杜兰(广州)生命基因工程科技有限公司 | Preparation method for concentrating stem cell paracrine factor and eliminating ineffective impurity protein |
| CN111676260A (en) * | 2020-05-09 | 2020-09-18 | 北京华牛世纪生物技术研究院 | Method for producing epidermal growth factor in mixed cell and simulated cell culture artificial nest device |
| CN111773173A (en) * | 2014-11-07 | 2020-10-16 | 胞外体干细胞株式会社 | Composition comprising stem cell-derived exosomes for adipogenic differentiation induction, adipose tissue regeneration, skin whitening or wrinkle improvement |
| CN113476601A (en) * | 2021-08-24 | 2021-10-08 | 天津汉青生物科技有限公司 | Medicine or cosmetic prepared by stem cell cytokine and algal polysaccharide |
| CN113699202A (en) * | 2020-05-21 | 2021-11-26 | 华子昂 | Method for preparing collagen by using mixed cell and artificial cell culture nest |
-
2009
- 2009-01-07 CN CNA2009100676348A patent/CN101461772A/en active Pending
Cited By (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102068391A (en) * | 2010-12-30 | 2011-05-25 | 广州赛莱拉化妆品科技有限公司 | Application of human steam cell growth factors in cosmetics |
| CN104662532A (en) * | 2011-03-28 | 2015-05-27 | 约翰·S·阿诺尼 | Commercial methods, processes and systems for collection, cryogenic storage and distribution of cosmetic formulations from obtained stem cell-based biomaterials |
| CN104203211A (en) * | 2012-02-10 | 2014-12-10 | 株式会社加帕尼克 | Iontophoresis method for cosmetics or skin regeneration promoters and proteins using culture supernatant of non-human stem cells as raw materials |
| CN107049910A (en) * | 2012-02-10 | 2017-08-18 | 株式会社加帕尼克 | Generating hair purposes, cosmetics or the skin of stem cell culture supernatant form the electro-ionic osmosis method of accelerator and protein |
| CN102600057B (en) * | 2012-03-16 | 2013-05-01 | 广州赛莱拉生物科技有限公司 | Human placenta stem cell extractive lyophilized powder as well as preparation method thereof and application thereof |
| CN102600057A (en) * | 2012-03-16 | 2012-07-25 | 广州赛莱拉生物科技有限公司 | Human placenta stem cell extractive lyophilized powder as well as preparation method thereof and application thereof |
| CN102895165B (en) * | 2012-10-29 | 2014-11-12 | 重庆市畜牧科学院 | Composite active matters of mask and preparation method of composite active matters |
| CN102895165A (en) * | 2012-10-29 | 2013-01-30 | 重庆市畜牧科学院 | Composite active matters of mask and preparation method of composite active matters |
| CN103110936A (en) * | 2013-03-15 | 2013-05-22 | 余玉宏 | Biological preparation for promoting quick growth and repair of skin tissue |
| CN104099294A (en) * | 2013-04-03 | 2014-10-15 | 北京京蒙高科干细胞技术有限公司 | Medium based on stem cell-excreted factor and its preparation method and use method |
| CN103784474A (en) * | 2014-01-26 | 2014-05-14 | 广州赛莱拉生物科技有限公司 | Human fat mesenchymal stem cell extract and lyophilized powder and application thereof |
| CN105078777A (en) * | 2014-05-15 | 2015-11-25 | 金凤华 | Mesenchymal stem cell excreted factor essence, and preparation method and application thereof |
| CN104107105A (en) * | 2014-07-22 | 2014-10-22 | 徐妍 | Cell factor cold application system for repairing skin injury and caring skin |
| CN104107105B (en) * | 2014-07-22 | 2016-03-02 | 徐妍 | A kind of cytokine cold compress system repairing skin injury and skin nursing |
| CN105505851A (en) * | 2014-10-14 | 2016-04-20 | 讯联生物科技股份有限公司 | Composition for promoting growth of dermal papilla cells, pharmaceutical composition and preparation method thereof |
| CN111773173A (en) * | 2014-11-07 | 2020-10-16 | 胞外体干细胞株式会社 | Composition comprising stem cell-derived exosomes for adipogenic differentiation induction, adipose tissue regeneration, skin whitening or wrinkle improvement |
| CN111773173B (en) * | 2014-11-07 | 2024-03-22 | 胞外体干细胞株式会社 | Composition for inducing adipogenic differentiation, regenerating adipose tissue, whitening skin or improving wrinkles comprising stem cell-derived exosomes |
| CN105030631A (en) * | 2014-12-12 | 2015-11-11 | 黄宗堂 | Stem cell face cream and preparation method thereof |
| CN104622777A (en) * | 2015-02-15 | 2015-05-20 | 广州赛莱拉干细胞科技股份有限公司 | Leukocyte extract and preparation method and application thereof |
| CN106282099A (en) * | 2015-05-29 | 2017-01-04 | 北京汉氏联合生物技术有限公司 | Preparation for the Placenta Hominis Subaerial blue green algae culture fluid of skin nursing and maintenance |
| CN104997708A (en) * | 2015-07-07 | 2015-10-28 | 河南中科干细胞基因工程有限公司 | Obtaining method of stem cell conditioned medium, and application of stem cell conditioned medium in skin ageing resistance |
| CN105749347A (en) * | 2016-02-24 | 2016-07-13 | 广州赛莱拉干细胞科技股份有限公司 | Cosmetic filler and preparation method thereof |
| CN108210441A (en) * | 2016-12-15 | 2018-06-29 | 烟台赛泽生物技术有限公司 | A kind of stem cell deep layer for cosmetology repairs Essence |
| CN106906268A (en) * | 2017-04-21 | 2017-06-30 | 优立赛尔（嘉兴）生物技术有限公司 | Cosmetically epidermal stem cells growth factor preparation method |
| CN107385007A (en) * | 2017-07-06 | 2017-11-24 | 杭州观梓健康科技有限公司 | A kind of method and its application for screening and contrasting a variety of stem cell secretion factor bioequivalences in people source |
| CN107385007B (en) * | 2017-07-06 | 2020-04-21 | 杭州观梓健康科技有限公司 | Method for screening and comparing bioequivalence of human-derived multiple stem cell secretion factors and application thereof |
| CN109097391A (en) * | 2018-07-11 | 2018-12-28 | 个体化细胞治疗技术国家地方联合工程实验室（深圳） | A kind of method and its application that decidua mescenchymal stem cell active factors are mass produced |
| CN109260139A (en) * | 2018-11-08 | 2019-01-25 | 深圳市茵冠生物科技有限公司 | A kind of stem cell skin care item and preparation method thereof |
| CN110339147A (en) * | 2018-11-27 | 2019-10-18 | 浙江梵泊细胞工程有限公司 | A kind of composition for external application and application thereof |
| CN109536441A (en) * | 2018-11-30 | 2019-03-29 | 佛山科学技术学院 | A kind of culture medium and preparation method thereof of fatty stem cell secretion object |
| CN110812309A (en) * | 2019-11-08 | 2020-02-21 | 曹文雁 | Formula for improving skin |
| CN111676260A (en) * | 2020-05-09 | 2020-09-18 | 北京华牛世纪生物技术研究院 | Method for producing epidermal growth factor in mixed cell and simulated cell culture artificial nest device |
| CN113699202A (en) * | 2020-05-21 | 2021-11-26 | 华子昂 | Method for preparing collagen by using mixed cell and artificial cell culture nest |
| CN111643390A (en) * | 2020-07-16 | 2020-09-11 | 卡杜兰(广州)生命基因工程科技有限公司 | Preparation method for concentrating stem cell paracrine factor and eliminating ineffective impurity protein |
| CN113476601A (en) * | 2021-08-24 | 2021-10-08 | 天津汉青生物科技有限公司 | Medicine or cosmetic prepared by stem cell cytokine and algal polysaccharide |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101461772A (en) | Method for preparing stem cell secretion factor for beauty treatment and skin-protection | |
| CN107854418A (en) | A kind of human umbilical cord mesenchymal stem cells excretion external use creams and preparation method thereof | |
| EP2368974A1 (en) | Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof | |
| CN101748096A (en) | Sub-totipotent stem cell, preparation method and application thereof | |
| CN103251649B (en) | The preparation method of human mesenchymal stem cell culture supernatant freeze-dried powder | |
| CN103898049B (en) | Living cell essence product and preparation method and application thereof | |
| CN103550117A (en) | Beauty and skin care product capable of promoting skin repairation and regeneration as well as preparation method and application thereof | |
| CN105056303A (en) | Composition, preparation and application thereof | |
| JP2012504598A (en) | Method for promoting skin cell growth, composition for treating skin condition or hair condition | |
| CN107823632A (en) | A kind of mesenchymal stem cells MSCs parenteral solution and preparation method | |
| CN105820998A (en) | Isolation extraction and culture method for human adipose-derived stem cells (ADSCs) for clinical back-transfusion grade cell therapy | |
| CN110339147A (en) | A kind of composition for external application and application thereof | |
| CN111956670A (en) | Preparation method of mesenchymal stem cells and active factor compound freeze-dried product thereof | |
| CN100508948C (en) | Production for skin beautification and care, and preparation method thereof | |
| CN103393585A (en) | Fibroblast liquid for beauty treatment and preparation method thereof | |
| CN115814045A (en) | Exosome composite preparation for improving alopecia and preparation method and application thereof | |
| CN109939062A (en) | A kind of sheep embryo or sheep placenta extract, preparation method and application in cosmetics | |
| CN105969726A (en) | Method for preparing adipose-derived stem cells by means of extraction | |
| CN115944653A (en) | A preparation containing stem cell exosome extract and its application in promoting hair growth or repairing skin regeneration | |
| Liubaviciute et al. | Modulated mesenchymal stromal cells improve skin wound healing | |
| CN111956668B (en) | Skin regeneration and repair cell composition and preparation method thereof | |
| CN102146359A (en) | Method for extracting original mesenchymal stem cells from placenta and serum-free amplification | |
| CN106701670A (en) | Methods for enhancing bioactive factor secretion capacity of mesenchymal stem cells and extracting active factors in culture solution | |
| CN103462865B (en) | Embryo water extract extracted from animal embryo skin and muscle, and extraction method and applications thereof | |
| CN111568851A (en) | Method for producing active factors by using perinatal MSC and cosmetic preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090624 |